Colorectal Cancer Drug

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin and Erbitux heralded a new era in the disease management, and the emergence of other molecular targeted agents should further push survival to an unprecedented level in the coming years.
There are today 270 (234) companies plus partners developing 330 (270) drugs targeting colorectal cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 141 (110) drugs. Colorectal Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 187 (155) different targets. These targets are further categorized on the CD-ROM by 58 (52) classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath. Figures in brackets are comparative data from last year.

Find and sort drugs by twelve different parameters plus free text search field. Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser, whether it is a single drug profile or an entire search you want have a report of.

How May Drug Pipeline Update Be of Use?

• Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
• Find competitors, collaborations partners, M&A candidates etc.
• Jump start competitive drug intelligence operations
• Excellent starting point for world wide benchmarking
• Compare portfolio and therapy focus with your peers
• Speed up pro-active in-/out licensing strategy work
• Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug.
• Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.

Drug Pipeline Update at a Glance

Investigators

Includes more than 270 (234) principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators.

Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator.

Drug name & Synonyms

Lists commercial, generic and code names for drugs.

Developmental stage

This Drug Pipeline Update contains 330 (270) drugs in active development for the treatment of colorectal cancer:
Marketed 15 (15)
Registered 1 (1)
Pre-registration 1
Phase III 9 (12)
Phase II 111 (98)
Phase I 85 (83)
Preclinical 78 (56)
No Data 17 (17)
Suspended 5
Discontinued 8

In addition there are 141 (110) ceased drugs.

Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application.

Indications

Included colorectal cancer drugs are also in development for 162 (120) other indications, where of 73 are different cancer indications.

Note: You are able to find and sort drugs according to type of indication from drop-down menu in the application.

Targets

Identified drugs are linked to more than 187 (155) different targets, divided into 58 (52) classifications of molecular function:

• ATPase activity
• Carboxy-lyase activity
• Catalytic activity
• Cell adhesion molecule activity
• Cofactor binding
• Complement activity
• Cysteine-type peptidase activity
• Cytokine activity
• Deacetylase activity
• DNA binding
• DNA repair protein
• DNA topoisomerase activity
• DNA-directed DNA polymerase activity
• DNA-methyltransferase activity
• Extracellular ligand-gated ion channel activity
• Extracellular matrix structural constituent
• Glutathione transferase activity
• G-protein coupled receptor activity
• Growth factor activity
• Guanylate cyclase activity
• Hormone activity
• Hydrolase activity
• Ion channel activity
• Kinase activity
• Kinase binding
• Kinase regulator activity
• Ligase activity
• Lipid kinase activity
• Lipid phosphatase activity
• Metallopeptidase activity
• Molecular function unknown
• Motor activity
• Oxidoreductase activity
• Peptidase activity
• Peroxidase activity
• Protease inhibitor activity
• Protein binding
• Protein serine/threonine kinase activity
• Protein threonine/tyrosine kinase activity
• Protein tyrosine phosphatase activity
• Protein-tyrosine kinase activity
• Receptor activity
• Receptor binding
• Receptor signaling complex scaffold activity
• Receptor signaling protein serine/threonine kinase activity
• RNA binding
• RNA-directed DNA polymerase activity
• Serine-type peptidase activity
• Structural constituent of cytoskeleton
• Structural molecule activity
• Transcription factor activity
• Transcription regulator activity
• Transferase activity
• Translation regulator activity
• Transmembrane receptor activity
• Transmembrane receptor protein tyrosine kinase activity
• Transporter activity
• Voltage-gated ion channel activity

Identified targets are categorized into 21 (20) different primary and alternate sub-cellular localizations:

• Centrosome
• Clathrin-coated vesicle
• Cytoplasm
• Cytosol
• Endoplasmic reticulum
• Endosome
• Extracellular
• Extracellular matrix
• Golgi apparatus
• Integral to membrane
• Lysosome
• Microtubule
• Mitochondrial membrane
• Mitochondrion
• Nuclear membrane
• Nucleolus
• Nucleus
• Perinuclear region
• Plasma membrane
• Secreted
• Secretory granule

Note: You are able to find and sort drugs according to target gene name, molecular function of target, and target localization from drop-down menus in the application.

Target Expression Profile

Direct links are provided from inside the application to 221 (180) protein expression profiles of 143 (120) drug targets in various human tissues and cancer types, cell lines and primary cells, including up to:

• 48 different normal tissue types
• 20 different types of cancer
• 47 cell lines
• 12 samples of primary blood cells

Pathway Referals

Identified targets have been cross referenced against their involvement in different cellular pathways, according to BioCarta, KEGG and NetPath.

• BioCarta 214 (206) Pathways
• KEGG 108 (72) Pathways
• NetPath 20 (20) Signaling Pathways

Note: You are able to find and sort drugs according to targeted pathways from drop-down menus in the application.

Mechanism

In total there are 242 (189) different drug mechanism of action represented in this Drug Pipeline Update.

Note: You are able to find and sort drugs according to mechanism of action from drop-down menu in the application.

Compound

Identified drug compounds are described by:

Compound type, Chemical name, CAS Number and molecular weight

Note: You are able to sort and find drugs according to compound type from drop-down menu in the application.

Drug Profile

Progress analysis and review of drug development. A typical drug profile reports on, depending on stage of development and available information:

Drug Name & Synonyms

Presentation of drug name and synonyms

Principal Investigator & Partners

Presentation of principal investigator and partners

Target and Molecular Function of Target

Described target(s) is/are presented with:
Official Gene Symbol - Official Gene Name [Species/Homo Sapiens] - Molecular Function

Target Localization

Described target(s) is/are presented with primary and alternate localizations.

Target Expression Profiles

Links to protein expression profile(s) of target(s) in various human tissues, cell lines and primary cells, including up to:

48 different normal tissue types

20 different types of cancer

47 cell lines

12 samples of primary blood cells

Targeted Pathways

Described target(s) is/are matched for the involvement in cellular pathways according to BioCarta, KEGG, and NetPath.

Mechanism

Drug mechanism of action

Developmental Projects

Summary field of developmental projects for the drug, including indication, developmental stage and status.

Example:

Cancer, myeloma - Phase II Clinical Trial - Active
Cancer, prostate - Phase III Clinical Trial - Ceased

Drug Description

Short introduction to drug

Compound Data

Compound type, Chemical name, CAS Number and molecular weight

Patent Data

Available patent information related to the drug is presented here.

Business & Markets

Collaborations and deals

Approvals and submissions

Analyst comments

Phase III Data

Available Phase III development data, developmental history and scientific data.

Phase II Data

Available Phase II development data, developmental history and scientific data.

Phase I Data

Available Phase I development data, developmental history and scientific data.

Preclinical Data

Available preclinical development data, developmental history and scientific data.

Licensing Information

Availability for licensing

Application Features

Use 13 different parameters, available in drop-down menus, to find and sort among drugs

• Drug status
• Clinical Trial Status
• Principle Investigator
• Partners
• Indication
• Developmental Stage
• Compound Type
• Mechanism
• Target
• Molecular Function of Target
• Target Localization
• Targeted Pathways
• Free text search of entire drug profile contents

Direct linkage from inside the application to related internet resources

• Drug data is linked to search engines like Google and PubMed
• Drug target data is linked directly to BioCarta, Human Protein Atlas, KEGG, and NetPath
• Direct links to company web pages of principal investigators

Dynamic Report Generator

Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser (Internet Explorer and FireFox), whether it is a single drug profile or an entire search you want have a report of.

System Requirements

• AMD-Athlon/Pentium II PC
• Windows 98/NT4/2000/ME/XP/VISTA/Windows 7
• 8x-speed CD Rom drive
• SVGA 16 bit display. (32 bit recommended)
• 32 MB of available RAM (128 MB recommended)
• Browser Application (Internet Explorer, Firefox)
• Internet access (to access related internet resources)

Please Note: Due to the Nature of This Report The Number of Pages and Toc is Not Available

Cancer Drug Discoveries: Colorectal Cancer What the future holds The worldwide incidence of colorectal cancer (CRC) is approximately one million cases per year and, in the US, it is the third most common cancer in both sexes, accounting for...

Pipeline Insight: Colorectal Cancer Growing trend towards personalized medicine Introduction CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel,...

Breast Cancer Drug Pipeline Update 2010 Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic...

Non-Small Cell Lung Cancer Drug Pipeline Update 2007 Lung cancer is the third most common malignant disease and the first leading cause of cancer death in the western world. Lately gefitinib, pemetrexed and erlotinib have entered the market...

Cancer Drug Discoveries What the Future Holds Understand the prospects for this US$47.2 billion market    Unique market share, sales forecasts by product to 2012    A comprehensive examination of five major oncology areas:    Breast cancer: Focusing on the...

View all products in this category